AGP Executive Report
Last update: 9 hours agoBiotech & Cancer Care: Antengene says two clinical abstracts for its Claudin 18.2 ADC ATG-022 and oral CD73 inhibitor ATG-037 were accepted for ESMO 2026 poster presentations, spotlighting new Phase II/Phase Ib-II results. Cross-Strait Health Industry Links: KoreaBIO urged closer biotech supply-chain cooperation with Taiwan at BIO Asia–Taiwan 2026, pointing to CDMO manufacturing, digital health, and startup investment opportunities. Food Safety & Public Health Governance: Taipei’s cooking oil scare continues to draw political pressure after benzopyrene-tainted batches triggered recalls and fines, with local leaders rallying against the handling of the crisis. Cancer Screening & Gut Health Research: NTUH highlights a potential 2-in-1 screening approach to cut gastric cancer deaths, while Chang Gung builds Taiwan’s first life-course gut microbiome database. Medical Ethics Debate: Taiwan’s euthanasia referendum push returns to the spotlight, with arguments that autonomy and suffering must be weighed alongside an overstretched medical system. Workplace Safety in Storms: Hong Kong’s Labour Department reminds employers to avoid electrical work during rainstorms and to follow safety procedures to prevent electric shock. Public Health in Emergencies: Papua New Guinea plans legislation to strengthen St John Ambulance as a national emergency service, aiming to improve coverage and response capacity.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
